Exemestane and Everolimus combination treatment of hormone receptor positive, HER2 negative metastatic breast cancer: A retrospective study of 9 cancer centers in the Campania Region (Southern Italy) focused on activity, efficacy and safetyFerdinando Riccardi, Michele Orditura, Raffaele Addeo et al.|Molecular and Clinical Oncology|2018Cited by 14
Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)Michele Orditura, Fortunato Ciardiello, Adriano Gravina et al.|ESMO Open|2017Cited by 13
Acceptance and Adherence of Oral Endocrine Therapy in Women with Metastatic Breast Cancer: Exacampania Group StudyRaffaele Addeo, Salvatore Del Prete, Patrizia Iodice et al.|The Breast Journal|2015Cited by 8
Multicenter observational study on adherence and acceptance of lapatinib treatment in patients with HER2+ metastatic breast cancer.Raffaele Addeo, S. Del Prete, Bruno Vincenzi et al.|Journal of Clinical Oncology|2011Cited by 2